Yanchun Peng

发表

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Nguyen H. Tran, Kathryn Jones, Tao Dong, 2020, The Lancet.

Examination of Influenza Specific T Cell Responses after Influenza Virus Challenge in Individuals Vaccinated with MVA-NP+M1 Vaccine

Tao Dong, Adrian V. S. Hill, Andrew J. McMichael, 2013, PloS one.

Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in Humans

Tao Dong, Adrian V. S. Hill, Tom Havelock, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Quantitating T Cell Cross-Reactivity for Unrelated Peptide Antigens1

Bjoern Peters, John Sidney, Alessandro Sette, 2009, The Journal of Immunology.